{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T08:06:15Z","timestamp":1768032375276,"version":"3.49.0"},"reference-count":28,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRR"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background::<\/jats:title>\n                    <jats:p>Lupus nephritis (LN) represents 40%-50% of all systemic lupus erythematosus\n(SLE) patients, and rapidly progressive glomerulonephritis is associated with significant morbidity\nand mortality. Antineutrophil cytoplasmic antibody (ANCA) might be involved in the pathogenesis\nof LN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective::<\/jats:title>\n                    <jats:p>We evaluated the role of myeloperoxidase (MPO)-ANCA, proteinase 3 (PR3)-ANCA,\nand anti-glomerular basement membrane autoantibodies (anti-GBM autoAb) for the diagnosis of\nLN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods::<\/jats:title>\n                    <jats:p>In this cross-sectional study, 95 SLE patients were divided into 2 subgroups: LN group\n(n = 60) and non-LN group (n = 35). For further analysis, we subclassified the LN group into ANCA-\npositive (n = 16) and ANCA-negative (n = 44) LN patients. The entire Non-LN group was ANCA-\nnegative. The SLE disease activity index (SLEDAI) was reported for each patient. Determination\nof MPO-ANCA, PR3-ANCA, and anti-GBM autoAb was performed using a novel multiplex\nbead-based technology in all patients. Data analyses were done using SPSS, version 20. Approval\nwas obtained from the institutional review board of Zagazig University (ZU-IRB#6000).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results::<\/jats:title>\n                    <jats:p>Of 95 patients with SLE, 16 patients (16.84%) had ANCA-positive LN, all of which were\nMPO-ANCA. There was a positive correlation between MPO-ANCA and SLEDAI, as well as with\nclass IV LN. Receiver operating characteristic analyses revealed that the sensitivity and specificity\nof MPO-ANCA were 81.3% and 99.8%, respectively, in discriminating LN from systemic lupus\nwithout nephritis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion::<\/jats:title>\n                    <jats:p>MPO-ANCA level was significantly correlated with SLEDAI, inflammatory markers,\nkidney function tests, and LN class IV.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1573397116999201208213422","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T04:48:21Z","timestamp":1607489301000},"page":"213-221","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antineutrophil Cytoplasmic Antibody in Lupus Nephritis: Correlation with Clinicopathological Characteristics and Disease Activity"],"prefix":"10.2174","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0244-2737","authenticated-orcid":true,"given":"Dina","family":"Said","sequence":"first","affiliation":[{"name":"Rheumatology and Rehabilitation Department, Faculty of Medicine, Zagazig University,Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1746-3514","authenticated-orcid":true,"given":"Nearmeen Mohammed","family":"Rashad","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Faculty of Medicine, Zagazig University,Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6125-1143","authenticated-orcid":true,"given":"Nora Said","family":"Abdelrahmanc","sequence":"additional","affiliation":[{"name":"Clinical Pathology Department, Faculty of Medicine, Zagazig University, Zagazig,Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7500-2447","authenticated-orcid":true,"given":"Ghada Aboelsaud","family":"Dawaa","sequence":"additional","affiliation":[{"name":"Clinical Pathology Department, Faculty of Medicine, Zagazig University, Zagazig,Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1002\/1529-0131(199810)41:10<1714::AID-ART3>3.0.CO;2-U","volume":"41","author":"Cooper G.S.","year":"1998","unstructured":"Cooper G.S.; Dooley M.A.; Treadwell E.L.; St Clair E.W.; Parks C.G.; Gilkeson G.S.; Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum 1998,41(10),1714-1724","journal-title":"Arthritis Rheum"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMra071297","volume":"358","author":"Rahman A.","year":"2008","unstructured":"Rahman A.; Isenberg D.A.; Systemic lupus erythematosus. N Engl J Med 2008,358(9),929-939","journal-title":"N Engl J Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"Petri M.","year":"2012","unstructured":"Petri M.; Orbai A.M.; Alarc&#xF3;n G.S.; Gordon C.; Merrill J.T.; Fortin P.R.; Bruce I.N.; Isenberg D.; Wallace D.J.; Nived O.; Sturfelt G.; Ramsey-Goldman R.; Bae S.C.; Hanly J.G.; S&#xE1;nchez-Guerrero J.; Clarke A.; Aranow C.; Manzi S.; Urowitz M.; Gladman D.; Kalunian K.; Costner M.; Werth V.P.; Zoma A.; Bernatsky S.; Ruiz-Irastorza G.; Khamashta M.A.; Jacobsen S.; Buyon J.P.; Maddison P.; Dooley M.A.; van Vollenhoven R.F.; Ginzler E.; Stoll T.; Peschken C.; Jorizzo J.L.; Callen J.P.; Lim S.S.; Fessler B.J.; Inanc M.; Kamen D.L.; Rahman A.; Steinsson K.; Franks A.G.; Sigler L.; Hameed S.; Fang H.; Pham N.; Brey R.; Weisman M.H.; McGwin G.; Magder L.S.; Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012,64(8),2677-2686","journal-title":"Arthritis Rheum"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0140-6736(07)60279-7","volume":"369","author":"D\u2019Cruz D.P.","year":"2007","unstructured":"D\u2019Cruz D.P.; Khamashta M.A.; Hughes G.R.; Systemic lupus erythematosus. Lancet 2007,369(9561),587-596","journal-title":"Lancet"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1445-5994.1984.tb03769.x","volume":"14","author":"Hall J.B.","year":"1984","unstructured":"Hall J.B.; Wadham B.M.; Wood C.J.; Ashton V.; Adam W.R.; Vasculitis and glomerulonephritis: a subgroup with an antineutrophil cytoplasmic antibody. Aust N Z J Med 1984,14(3),277-278","journal-title":"Aust N Z J Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"656","DOI":"10.7326\/0003-4819-113-9-656","volume":"113","author":"Falk R.J.","year":"1990","unstructured":"Falk R.J.; Hogan S.; Carey T.S.; Jennette J.C.; Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. Ann Intern Med The Glomerular Disease Collaborative Network1990,113(9),656-663","journal-title":"Ann Intern Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1053\/ajkd.2000.17615","volume":"36","author":"Haas M.","year":"2000","unstructured":"Haas M.; Jafri J.; Bartosh S.M.; Karp S.L.; Adler S.G.; Meehan S.M.; ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits. Am J Kidney Dis 2000,36(4),709-718","journal-title":"Am J Kidney Dis"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jaut.2014.01.024","volume":"48-49","author":"Hellmark T.","year":"2014","unstructured":"Hellmark T.; Segelmark M.; Diagnosis and classification of Goodpasture\u2019s disease (anti-GBM). J Autoimmun 2014,48-49,108-112","journal-title":"J Autoimmun"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMra071297","volume":"358","author":"Rahman A.","year":"2008","unstructured":"Rahman A.; Isenberg D.A.; Systemic lupus erythematosus. N Engl J Med 2008,358(9),929-939","journal-title":"N Engl J Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.autrev.2007.12.001","volume":"7","author":"Yung S.","year":"2008","unstructured":"Yung S.; Chan T.M.; Anti-DNA antibodies in the pathogenesis of lupus nephritis--the emerging mechanisms. Autoimmun Rev 2008,7(4),317-321","journal-title":"Autoimmun Rev"},{"key":"ref=11","first-page":"S112","volume":"32","author":"Sinico R.A.","year":"2014","unstructured":"Sinico R.A.; Radice A.; Antineutrophil cytoplasmic antibodies (ANCA) testing: detection methods and clinical application. Clin Exp Rheumatol 2014,32(3)(Suppl. 82),S112-S117","journal-title":"Clin Exp Rheumatol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"Jennette J.C.","year":"1994","unstructured":"Jennette J.C.; Falk R.J.; Andrassy K.; Bacon P.A.; Churg J.; Gross W.L.; Hagen E.C.; Hoffman G.S.; Hunder G.G.; Kallenberg C.G.; Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994,37(2),187-192","journal-title":"Arthritis Rheum"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-pathol-011811-132453","volume":"8","author":"Jennette J.C.","year":"2013","unstructured":"Jennette J.C.; Falk R.J.; Hu P.; Xiao H.; Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annu Rev Pathol 2013,8,139-160","journal-title":"Annu Rev Pathol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1309\/WAEPADW0K4LPUHFN","volume":"120","author":"Savige J.","year":"2003","unstructured":"Savige J.; Dimech W.; Fritzler M.; Goeken J.; Hagen E.C.; Jennette J.C.; McEvoy R.; Pusey C.; Pollock W.; Trevisin M.; Wiik A.; Wong R.; Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases. Am J Clin Pathol International Group for Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)2003,120(3),312-318","journal-title":"Am J Clin Pathol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"Bombardier C.","year":"1992","unstructured":"Bombardier C.; Gladman D.D.; Urowitz M.B.; Caron D.; Chang C.H.; Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum The Committee on Prognosis Studies in SLE1992,35(6),630-640","journal-title":"Arthritis Rheum"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/art.21625","volume":"54","author":"Liang M.H.","year":"2006","unstructured":"Liang M.H.; Schur P.H.; Fortin P.; The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria2006,54(2),421-432","journal-title":"Arthritis Rheum"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1177\/0961203309358187","volume":"19","author":"Ortega L.M.","year":"2010","unstructured":"Ortega L.M.; Schultz D.R.; Lenz O.; Pardo V.; Contreras G.N.; Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions. Lupus 2010,19(5),557-574","journal-title":"Lupus"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/ki.1996.528","volume":"50","author":"Moroni G.","year":"1996","unstructured":"Moroni G.; Quaglini S.; Maccario M.; Banfi G.; Ponticelli C.; &#x201C;Nephritic flares&#x201D; are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int 1996,50(6),2047-2053","journal-title":"Kidney Int"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1128\/CVI.00034-07","volume":"14","author":"Avaniss-Aghajani E.","year":"2007","unstructured":"Avaniss-Aghajani E.; Berzon S.; Sarkissian A.; Clinical value of multiplexed bead-based immunoassays for detection of autoantibodies to nuclear antigens. Clin Vaccine Immunol 2007,14(5),505-509","journal-title":"Clin Vaccine Immunol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fimmu.2015.00181","volume":"6","author":"Satoh M.","year":"2015","unstructured":"Satoh M.; Tanaka S.; Chan E.K.; The uses and misuses of multiplex autoantibody assays in systemic autoimmune rheumatic diseases. Front Immunol 2015,6,181","journal-title":"Front Immunol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nrrheum.2014.78","volume":"10","author":"Csernok E.","year":"2014","unstructured":"Csernok E.; Moosig F.; Current and emerging techniques for ANCA detection in vasculitis. Nat Rev Rheumatol 2014,10(8),494-501","journal-title":"Nat Rev Rheumatol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.krcp.2015.11.002","volume":"35","author":"Abdallah E.","year":"2016","unstructured":"Abdallah E.; Waked E.; Abdelwahab M.A.; Evaluating the association of interleukin-10 gene promoter -592 A\/C polymorphism with lupus nephritis susceptibility. Kidney Res Clin Pract 2016,35(1),29-34","journal-title":"Kidney Res Clin Pract"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"e2580","DOI":"10.1097\/MD.0000000000002580","volume":"95","author":"Wang Y.","year":"2016","unstructured":"Wang Y.; Huang X.; Cai J.; Xie L.; Wang W.; Tang S.; Yin S.; Gao X.; Zhang J.; Zhao J.; Huang Y.; Li Y.; Zhang Y.; Zhang J.; Clinicopathologic characteristics and outcomes of lupus nephritis with antineutrophil cytoplasmic antibody: a retrospective study. Medicine (Baltimore) 2016,95(4),e2580","journal-title":"Medicine (Baltimore)"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrrheum.2014.103","volume":"10","author":"Jennette J.C.","year":"2014","unstructured":"Jennette J.C.; Falk R.J.; Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev Rheumatol 2014,10(8),463-473","journal-title":"Nat Rev Rheumatol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrneph.2015.33","volume":"11","author":"Mohan C.","year":"2015","unstructured":"Mohan C.; Putterman C.; Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat Rev Nephrol 2015,11(6),329-341","journal-title":"Nat Rev Nephrol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1001\/jama.2014.6634","volume":"311","author":"Coresh J.","year":"2014","unstructured":"Coresh J.; Turin T.C.; Matsushita K.; Sang Y.; Ballew S.H.; Appel L.J.; Arima H.; Chadban S.J.; Cirillo M.; Djurdjev O.; Green J.A.; Heine G.H.; Inker L.A.; Irie F.; Ishani A.; Ix J.H.; Kovesdy C.P.; Marks A.; Ohkubo T.; Shalev V.; Shankar A.; Wen C.P.; de Jong P.E.; Iseki K.; Stengel B.; Gansevoort R.T.; Levey A.S.; Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 2014,311(24),2518-2531","journal-title":"JAMA"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/rheumatology\/31.10.669","volume":"31","author":"Lee S.S.","year":"1992","unstructured":"Lee S.S.; Lawton J.W.; Chan C.E.; Li C.S.; Kwan T.H.; Chau K.F.; Antilactoferrin antibody in systemic lupus erythematosus. Br J Rheumatol 1992,31(10),669-673","journal-title":"Br J Rheumatol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000013557","volume":"20","author":"Chin H.J.","year":"2000","unstructured":"Chin H.J.; Ahn C.; Lim C.S.; Chung H.K.; Lee J.G.; Song Y.W.; Lee H.S.; Han J.S.; Kim S.; Lee J.S.; Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis. Am J Nephrol 2000,20(1),57-63","journal-title":"Am J Nephrol"}],"container-title":["Current Rheumatology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573397116999201208213422","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/188874\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573397116999201208213422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T19:04:48Z","timestamp":1761332688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/188874\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573397116999201208213422","relation":{},"ISSN":["1573-3971"],"issn-type":[{"value":"1573-3971","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-05-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}